Table of contents

Papers

• HDAC inhibitor therapy in autoimmunity and transplantation (28 March, 2012)

  Wayne W Hancock, Tatiana Akimova, Ulf H Beier, Yujie Liu, Liqing Wang
• TNF and EPO: major players in the innate immune response: their discovery (28 March, 2012)

  Anthony Cerami
• Leishmaniasis in rheumatology, haematology and oncology: epidemiological, immunological and clinical aspects and caveats (28 March, 2012)

  Christian Bogdan
• How do contemporary imaging techniques contribute to basic and clinical rheumatology? (28 March, 2012)

  Masaru Ishii
• In vitro and in vivo analysis of a JAK inhibitor in rheumatoid arthritis (28 March, 2012)

  Y Tanaka, Y Maeshima, K Yamaoka
• Antisense oligonucleotide mediated exon skipping as a potential strategy for the treatment of a variety of inflammatory diseases such as rheumatoid arthritis (28 March, 2012)

  Seda Yilmaz-Elis, Annemieke Aartsma-Rus, Anne Vroon, Judith van Deutekom, Sjef de Kimpe, Peter A C 't Hoen, Gert-Jan van Ommen, J Sjef Verbeek
• CD3 ζ defects in systemic lupus erythematosus (28 March, 2012)

  Tsutomu Takeuchi, Katsuya Suzuki, Tsuneo Kondo, Keiko Yoshimoto, Kensei Tsuzaka
• New approaches to the assessment and treatment of the idiopathic inflammatory myopathies (28 March, 2012)

  Frederick W Miller
• Defining remission in rheumatoid arthritis (28 March, 2012)

  David Felson
• Remission by imaging in rheumatoid arthritis: should this be the ultimate goal? (28 March, 2012)

  Désirée van der Heijde
• How to define remission in ankylosing spondylitis? (28 March, 2012)

  Joachim Sieper
• Roles of LAG3 and EGR2 in regulatory T cells (28 March, 2012)

  Tomohisa Okamura, Keishi Fujio, Shuji Sumitomo, Kazuhiko Yamamoto
• IL-33: a Janus cytokine (28 March, 2012)

  F Y Liew